Pharma News

Keep updating your pharma knowledge
24 Apr 2020

Florio GmbH introducing new digital platform aiming to improve the lives of people with haemophilia

Posted By

Swedish Orphan Biovitrum AB (publ) (Sobi) has announced the launch by its affiliate, Florio GmbH, of Florio, a digital medical device designed with the aim to improve the quality of life for people with haemophilia.

Consisting of a smartphone app which can be combined with a wearable device and a web-based dashboard for physicians, Florio allows patients to track, monitor and share data relating to their health in real-time with their health care teams to enable personalised care.

The new technology is intended to enable meaningful discussions between physicians and people living with haemophilia, aimed at reducing the uncertainty around treatment so patients with haemophilia are able to lead full and active lives. Florio was developed with extensive input from both health care professionals and people with haemophilia, further supporting Sobi’s long term commitment to the community.

Florio is a CE-marked digital medical device. With the goal of enabling life beyond haemophilia, it aims to give haemophilia patients individual insights and thereby enable them to make informed choices and live life to the fullest. It allows patients to share personal disease-related information with their healthcare team in real-time, enabling more meaningful consultation between patients and physicians to allow for truly personalised care. Florio was developed by Florio GmbH, an affiliate established as a separate company within Sobi.

KPE-C-063 KPE’s 1 Month Certificate Course in Digital Pharma Marketing

KPE – C- 024 KPE’s Executive Program in Pharmaceutical Global Business

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!